Synthetic Biology
Twist Bioscience, Artisan Development Labs Collaborate on Antibody Discovery, Cell Therapies
Twist will receive upfront technology access and project fees; success-based clinical, regulatory, and commercial milestones; and royalties.
Twist Bioscience Sees Demand for New Enzymatic DNA Synthesis Method; Stays Mum on Timeline, Details
Premium
The South San Francisco-based company claims the new technique is plug-and-play, low cost, scarless, and scalable but said it needs more engineering.
BTIG Initiates Coverage of Ginkgo Bioworks With Buy Rating
By spreading products across industries, Ginkgo will have access to a total addressable market of $2 trillion-$4 trillion annually, BTIG says.
With $40 million in VC funding, the firm also intends to hire an international sales force and build a new generation of Cyto-Mine instruments with laser optics.
DNA Script Receives CE Mark for Syntax Enzymatic DNA Synthesis Platform
The CE marking covers the benchtop instrument, reagents, and consumables, which DNA Script will now begin selling commercially within Europe.
Nov 4, 2021
Berkeley Lights Revenues Grow 34 Percent in Q3
Oct 26, 2021
DNA Script Raises $165M in Series C Funding Round
Sep 28, 2021
Sep 22, 2021
Hexagon Bio Raises $61M in Private Financing Round
Jun 23, 2021
Codex DNA Closes $122.7M IPO
Jun 11, 2021
May 17, 2021
Ginkgo Bioworks Acquires Dutch DNA Biotech
May 7, 2021